loadpatents
Patent applications and USPTO patent grants for SUMMIT THERAPEUTICS PLC.The latest application filed is for "compounds for the treatment of clostridium difficile associated disease".
Patent | Date |
---|---|
Antibacterial compounds Grant 9,763,925 - Wilson , et al. September 19, 2 | 2017-09-19 |
Compounds For The Treatment Of Clostridium Difficile Associated Disease App 20170217983 - Johnson; Peter David ;   et al. | 2017-08-03 |
Antibacterial Compounds App 20160184283 - WILSON; Francis Xavier ;   et al. | 2016-06-30 |
Compounds For The Treatment Of Clostridium Difficile Associated Disease App 20160145266 - Johnson; Peter David ;   et al. | 2016-05-26 |
Antibacterial compounds Grant 9,314,456 - Wilson , et al. April 19, 2 | 2016-04-19 |
Compounds for the treatment of Clostridium difficile associated disease Grant 9,278,091 - Johnson , et al. March 8, 2 | 2016-03-08 |
SEC | 0001599298 | Summit Therapeutics plc of UNITED KINGDOM |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.